Clinical Trial 56341

Northridge, CA 91325


Vitiligo - Northridge CA (Metro Los Angeles)
Click image to enlarge

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo- Controlled, Efficacy, and Safety Study of Povorcitinib in Participants with Nonsegmental Vitiligo

Must be:
18 or older

Medically diagnosed with Nonsegmental vitiligo

Can not currently or have history of use of depigmenting agent monobenzyl ether of hydroquinone, such as Benoquin

Can not have any history of surgical treatment for vitiligo

Can not have currently have or had any history of the following
a. Thrombocytopenia, coagulopathy, or platelet dysfunction
b. Venous or arterial thrombosis, deep vein thrombosis, pulmonary embolism,
stroke, moderate to severe heart failure, myocardial infarction, or coronary
c. any diagnosis of other significant cardiovascular diseases  

Can not have uncontrolled hypertension (defined as more than 160/100)

Can not have ever received an organ transplant 

Can not currently or have history of HIV or an acquired immunodeficiency syndrome

Can not have any known hypersensitivity or severe reaction to Povorcitinib or to any other products in the same class

Must provide pictures of vitiligo to ensure screening eligibility

Qualified Participants May Receive:

Compensation for time and travel up to $2,000

No cost study medication

No cost study lab examination

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.